2017-03-10,Ocera Therapeutics Reports Fourth Quarter And Full Year 2016 Financial Results And Provides Corporate Update
2017-03-08,Ocera To Announce Additional Encouraging Results From Its Phase 2b STOP-HE Study Of IV OCR-002 In Patients With Hepatic Encephalopathy
2017-02-28,Ocera To Present At The Cowen And Company 37th Annual Healthcare Conference
2017-02-17,Lifshitz & Miller LLP Announces Investigation Of Centrue Financial Corporation, Motorola Solutions, Inc., Natus Medical Incorporated, Northern Dynasty Minerals Ltd., Ocera Therapeutics, Inc., Psychemedics Corporation, RH And Stemline Therapeutics, Inc.
2017-02-02,SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces The Commencement Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Ocera Therapeutics, Inc.
2017-01-30,Ocera Announces Top-line Results For Phase 2b Study In Hepatic Encephalopathy
2017-01-05,Ocera Announces Successful Phase 1 Clinical Study Of Orally-Administered OCR-002 In Patients With Cirrhosis
2016-12-07,Ocera Completes Enrollment Of STOP-HE, A Phase 2b Study Of OCR-002 In Hospitalized Patients With Hepatic Encephalopathy
2016-11-09,Ocera To Present At The Stifel 2016 Healthcare Conference
2016-11-02,Ocera Therapeutics Reports Third Quarter 2016 Financial Results And Company Update
2016-10-28,Ocera Therapeutics Appoints Biopharmaceutical Veteran Willard Dere, M.D. To Board Of Directors
2016-10-24,Ocera Therapeutics Announces Late-Breaker Abstract Accepted For Presentation At The AASLD Liver Meeting 2016
2016-10-10,Ocera To Present At The 2016 BIO Investor Forum
2016-09-21,Ocera Announces Enrollment Completion From Phase 2a NIH-Sponsored Study Of OCR-002 In The Treatment Of Patients With Acute Liver Failure
2016-09-20,Ocera To Present At The Ladenburg Thalmann 2nd Annual Healthcare Conference
2016-09-19,Ocera Initiates Phase 1 Clinical Study Of Orally Available OCR-002 In Patients With Cirrhosis For The Prevention Of Hepatic Encephalopathy
2016-09-15,Ocera Announces Management Transition
2016-08-03,Ocera Therapeutics Reports Second Quarter 2016 Financial Results And Company Update
2016-06-13,Ocera To Present At The JMP Securities Life Sciences Conference
2016-05-31,Ocera To Present At The Jefferies 2016 Healthcare Conference
2016-05-26,Ocera To Present At The 2016 BIO International Convention
2016-04-29,Ocera Therapeutics Reports First Quarter 2016 Financial Results And Pipeline Progress
2016-04-15,Ocera Therapeutics Announces Presentation Of Two Preclinical Studies Further Supporting Its Ammonia Scavenger OCR-002 At The International Liver Congressâ„¢ 2016 Of The European Association For The Study Of The Liver (EASL)
2016-04-11,Ocera Therapeutics Announces Publication Of Promising Preclinical Data In Support Of Its Ammonia Scavenger OCR-002 In The Journal Of Hepatology
2016-04-05,Ocera To Present At The 15th Annual Needham Healthcare Conference
2016-03-03,Ocera Therapeutics Reports Fourth Quarter And Full Year 2015 Financial Results And Provides Corporate Update
2016-02-29,Ocera To Present At The Cowen And Company 36th Annual Health Care Conference
2016-02-02,Ocera To Present At The 18th Annual BIO CEO & Investor Conference
2016-01-08,Ocera Announces Complete Plasma Data From Pilot Phase 1 Study For Orally-Available OCR-002 In Development For The Prevention Of Chronic Hepatic Encephalopathy
2016-01-07,Ocera Appoints Dr. Stan Bukofzer As Chief Medical Officer
2015-11-17,Ocera (OCRX) Stock Rises on Positive Drug Trial Results
2015-11-16,Ocera Announces Positive Phase 1 Results For Oral OCR-002 In Development For The Prevention Of Chronic Hepatic Encephalopathy
2015-11-09,Ocera To Present At Stifel 2015 Healthcare Conference
2015-11-04,Ocera Therapeutics Reports Third Quarter 2015 Financial Results
2015-10-13,Ocera To Present At BIO Investor Forum 2015
2015-10-05,Ocera Therapeutics Highlights OCR-002 Data To Be Presented At The Annual Meeting Of The American Association For The Study Of Liver Diseases (AASLD)
2015-09-24,5 Stocks Under $10 Set to Soar
2015-09-16,Ocera Initiates Phase 1 Clinical Trial Of Oral Drug Candidate OCR-002 For Prevention Of Hepatic Encephalopathy
2015-09-01,Ocera To Present At The Rodman & Renshaw 17th Annual Global Investment Conference
2015-08-03,Ocera Therapeutics Reports Second Quarter 2015 Financial Results
2015-07-30,Ocera Therapeutics Secures $20 Million Debt Facility From Oxford Finance And Silicon Valley Bank
2015-06-25,Insider Trading Alert - SWHC, MTSI And OCRX Traded By Insiders
2015-06-16,Ocera Therapeutics To Present At The JMP Securities Life Sciences Conference
2015-05-29,Ocera Therapeutics To Present At The Jefferies 2015 Healthcare Conference
2015-05-07,Insider Trading Alert - DXCM, FDP And OCRX Traded By Insiders
2015-05-04,Ocera CEO To Be Honored At The 17th Annual American Liver Foundation's Salute To Excellence Awards Gala In San Francisco
2015-05-04,Ocera Therapeutics Announces Change In Executive Team
2015-04-30,Ocera Reports Pipeline Progress And First Quarter 2015 Financial Results
2015-04-22,Ocera Therapeutics To Report Pipeline Progress And First Quarter 2015 Financial Results
2015-04-01,Ocera Completes Interim Analysis Of OCR-002 In Phase 2b STOP-HE Study For The Treatment Of Acute Hepatic Encephalopathy
2015-03-11,Ocera Reports Fourth Quarter And Full Year 2014 Financial Results
2015-03-02,Ocera Therapeutics To Announce Fourth Quarter And Full Year 2014 Financial Results
2015-02-23,Ocera Therapeutics To Present At 35th Annual Cowen And Company Health Care Conference
2015-02-18,Ocera Announces Preliminary Topline Results From Phase 2a Investigator-Sponsored Study Of OCR-002
2014-12-03,Ratings Changes Today
2014-12-03,Ratings Changes Today
2014-12-03,Ocera Therapeutics Promotes Michael Byrnes To Chief Financial Officer
2014-11-13,Ocera Reports Third Quarter 2014 Financial Results
2014-11-10,Ocera Therapeutics To Present At Stifel 2014 Healthcare Conference
2014-11-04,Ocera Therapeutics To Announce Third Quarter 2014 Financial Results
2014-09-29,Ocera Therapeutics To Present At 13th Annual BIO Investor Forum
2014-09-18,Ocera Therapeutics Announces Appointment Of Steven P. James To Board
2014-08-11,Ocera Announces Appointment Of Rajiv Patni, M.D. As Chief Development Officer
2014-08-11,Ocera Reports Second Quarter 2014 Financial Results
2014-07-31,Ocera Therapeutics To Announce Second Quarter Financial Results
2014-07-10,Why Ocera Therapeutics (OCRX) Stock Is Plunging Today
2014-07-10,Ocera Therapeutics Raises $25.2 Million In Public Offering
2014-07-09,Ocera Therapeutics Announces Proposed Public Offering Of Common Stock
2014-06-17,Ocera Therapeutics To Present At The JMP Securities Healthcare Conference 2014
2014-05-21,Ocera Therapeutics To Present At The Jefferies 2014 Global Healthcare Conference
2014-05-08,Ocera Reports First Quarter Financial Results
2014-05-08,Ocera Therapeutics Becomes Oversold (OCRX)
2014-05-02,Ocera Therapeutics Announces Appointment Of Gaurav Aggarwal, M.D., As Chief Business Officer
2014-04-29,Ocera Therapeutics To Announce First Quarter Financial Results
2014-03-31,Oversold Conditions For Ocera Therapeutics (OCRX)
2014-03-13,Ocera Reports Fourth Quarter And Year-End 2013 Financial Results
2014-03-06,3 Stocks Rising on Big Volume
2014-03-04,Ocera Therapeutics To Announce Fourth Quarter And Year End Financial Results
2014-02-26,Ocera Therapeutics To Present At The Cowen And Company 34th Annual Health Care Conference
2014-02-19,5 Stocks Poised to Skyrocket Higher
2014-01-08,Ocera Therapeutics Announces Enrollment Of The First Patient In A Phase IIb Study For Treatment Of Acute Hepatic Encephalopathy
2013-12-24,Ocera Therapeutics Announces Election Of Wendell Wierenga To Board
2013-12-17,Ocera Therapeutics And The Roche Group Enter Into Technology Transfer And License Agreement
2013-12-11,Ocera Therapeutics Announces Staffing Transition
2013-11-26,Ocera Therapeutics To Present At Piper Jaffrey Healthcare Conference
2013-11-13,Ocera Reports Third Quarter Business Update And Financial Results
2013-11-06,Ocera Therapeutics Announces $28 Million Private Placement
2013-09-25,Ocera Therapeutics To Present At BIO Investor On October 8, 2013
2013-09-17,Ocera Announces Post-Merger Closure Of Quebec Research Site
2013-09-03,Jeryl L. Hilleman Joins Ocera Therapeutics As Chief Financial Officer
2013-08-13,Ocera Therapeutics Announces Second Quarter 2013 Financial Results
2013-07-26,Ocera Therapeutics To Report Second Quarter 2013 Financial Results
,
,
